Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Analysis of Clinical Characterization of CMML.

Suijing Wu, MD, Xin Du, PhD, Wei Lin, Zilun Huang, Jianyu Weng, MD, Zhixin Huang, Maohua Zhou, MD, Jianhua Su, Zesheng Lu

Blood (2009) 114 (22): 4853.

https://doi.org/10.1182/blood.V114.22.4853.4853

Published: 2009

Journal Articles

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

Weng Jianyu, MD, Xin Du, MD, PhD, Xiang Peng, MD, Zhang Xiumin, MD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, MD, Chengxin Deng, MD, Wei Ling, MD, Wei Lin, MD, Zilun Huang, MD

Blood (2007) 110 (11): 4968.

https://doi.org/10.1182/blood.V110.11.4968.4968

Published: 2007

Journal Articles

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

Xin Du, MD, PhD, Yangqiu Li, MD, Suxia Geng, MD, Jianyu Weng, MD, Zesheng Lu, MD, Suijin Wu, MD, Chenxin Deng, MD, Wei Ling, MD, Haizhou Xing, MD, Changchun Wan, MD, Chenwei Luo, MD, Liye Zhong, MD, Miaorong She, MD, Xiaoli Zhou, MD, Qunhua Li, MD, Wei Lin, MD, Zilun Huang, MD, Shaohua Chen, MD

Blood (2007) 110 (11): 4970.

https://doi.org/10.1182/blood.V110.11.4970.4970

Published: 2007

Journal Articles

Efficacy and Safety of Gemtuzumab-Based Regimens in Patients with CD33-Positive Refractory Leukemia.

Suijing Wu, MD, Xin Du, MD, PhD, Wei Lin, MD, Jianyu Weng, MD, Jianjun Zhang, MD, Maohua Zhou, MD, Zhixin Huang, MD, Jianhua Su, MD, Zilun Huang, MD, Zesheng Lu, MD

Blood (2007) 110 (11): 4358.

https://doi.org/10.1182/blood.V110.11.4358.4358

Published: 2007

Journal Articles

Elderly Acute Myeloid Leukemia: A Retrospective Analysis of 89 Cases in China.

Zesheng Lu, MD, Xin Du, Ph.d, Yi Long, MD, Jianyu Weng, MD, Wei Lin, MD, Zilun Huang, MD

Blood (2005) 106 (11): 4621.

https://doi.org/10.1182/blood.V106.11.4621.4621

Published: 2005

Journal Articles

CD4 + CD28 + T Lymphoctye Subsets Decreased in Healthy Donors after G-CSF Mobilization.

Jianyu Weng, MD, Xin Du, Ph.D, Jianjun Zhang, MD, Suijin Wu, MD, Zesheng Lu, MD, Maohua Zhou, MD, Wei Lin, MD, Zilun Huang, MD

Blood (2005) 106 (11): 3922.

https://doi.org/10.1182/blood.V106.11.3922.3922

Published: 2005

NARROW

Analysis of Clinical Characterization of CMML.

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

Efficacy and Safety of Gemtuzumab-Based Regimens in Patients with CD33-Positive Refractory Leukemia.

Elderly Acute Myeloid Leukemia: A Retrospective Analysis of 89 Cases in China.

CD4 + CD28 + T Lymphoctye Subsets Decreased in Healthy Donors after G-CSF Mobilization.

Email alerts

ASH Publications

American Society of Hematology

Analysis of Clinical Characterization of CMML.

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

Efficacy and Safety of Gemtuzumab-Based Regimens in Patients with CD33-Positive Refractory Leukemia.

Elderly Acute Myeloid Leukemia: A Retrospective Analysis of 89 Cases in China.

CD4 + CD28 + T Lymphoctye Subsets Decreased in Healthy Donors after G-CSF Mobilization.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only